Urban-rural disparities in acceptance of human papillomavirus vaccination among women in Can Tho, Vietnam
Keywords:
HPV vaccination, cervical cancer, women, urban, rural VietnamAbstract
Background. In Vietnam, cervical cancer is a significant public health concern for women. Unfortunately, despite the availability of the HPV vaccine, low vaccination rates persist.
Objectives. This study investigates the discrepancy between urban and rural areas in the willingness to receive HPV vaccination with or without fees.
Methods. A cross-sectional study was conducted on a sample of 648 women aged between 15 and 49, living in two urban and two rural Vietnamese districts of Can Tho, between May and December 2021.
Results. The overall vaccination rate was 4%, with urban women having a higher rate of 4.9% compared to rural women at 3.1%. Among unvaccinated women, those from rural areas expressed a significantly higher desire to receive the free vaccine (91.4%) than urban women (84.4%). However, the intention to vaccinate declined when rural women and urban women were advised to pay the cost (63.4% and 57.1%, respectively). A strong correlation was found between a positive attitude and intention for vaccination, irrespective of its price or free availability. Education and access to information about the HPV vaccine were also identified as the most significant factors influencing the intention to vaccination among urban and rural women.
Conclusion. The low HPV vaccination rates among women aged 15-49 living in both urban and rural regions of Vietnam are a notable public health concern. These outcomes emphasize the critical need for effective programs of vaccine laterization, as an introduction to the offer of affordable and accessible HPV vaccines for women in Can Tho, Vietnam
References
1. World Health Organization (WHO). Comprehensive Cervical Cancer Control. A guide to essential practice. 2.ed. 2014. Available on: https://apps.who.int/iris/handle/10665/144785 [Last accessed: 2023 Apr 2].
2. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May; 71(3): 209-49. doi:10.3322/caac.21660. Epub 2021 Feb 4.
3. Bruni L, Albero G, Serrano B, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. Available on: https://hpvcentre. net/statistics/reports/XWX.pdf [Last accessed: 2023 Apr 4].
4. Touch S, Oh JK. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia. BMC Cancer. Mar 15; 18(1):294. doi: 10.1186/ s12885-018-4198-8.
5. Ferris DG, Brown DR, Giuliano AR, et al. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Res. 2020 Dec; 10: 100202. doi: 10.1016/j. pvr.2020.100202. Epub 2020 May 25.
6. Vu LT, Bui D, Le HT. Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign. BMC Cancer. 2013 Feb 4; 13: 53. doi: 10.1186/1471-2407 -13-53.
7. Hoang HT, Ishizaki A, Nguyen CH, et al. Infection with high-risk HPV types among female sex workers in northern Vietnam. J Med Virol. 2013 Feb; 85(2): 288-94. doi: 10.1002/jmv.23456. Epub 2012 Nov 14.
8. Vu LT. High-risk and multiple human papillomavirus infections among married women in Can Tho, Viet Nam. Western Pac Surveill Response J. 2012 Jul 31; 3(3): 57-62. doi: 10.5365/ WPSAR.2012.3.1.007.
9. Vu L, Le H, Luong O, Tran H, Nguyen N, Luu H. Prevalence of cervical human papillomavirus infection among married women in Hanoi, Vietnam, 2010. Asia Pac J Public Health. 2012 Mar; 24(2): 385-90. doi: 10.1177/1010539510393727. Epub 2011 Feb 28.
10. Pham QD, Prem K, Le TA, et al. Prevalence and risk factors for human papillomavirus infection among female sex workers in Hanoi and Ho Chi Minh City, Viet Nam: a crosssectional study. Western Pac Surveill Response J. 2022 Nov 7; 13(4): 1-11. doi: 10.5365/ wpsar.2022.13.4.894.
11. Nam DT, Dung TC, Duong NTT, et al. Prevalence of Human Papillomavirus (HPV) infection and genotype distribution among women in Vietnam: A literature review to improve health programs against anogenital cancer. Project: Emerging and re-emerging Infectious diseases. December 2017.
12. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal
Wkly Rep. 2019 Aug 16; 68(32): 698-702. doi: 10.15585/mmwr.mm6832a3.
13. Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine. 2013 Aug 20; 31(37): 3811-7. doi: 10.1016/j.
vaccine.2013.06.016. Epub 2013 Jun 15.
14. Le XTT, Nguyen PTN, Do TTT, et al. Intention to Pay for HPV Vaccination among Women of Childbearing Age in Vietnam. Int J Environ Res Public Health. 2020 Apr 30; 17(9): 3144. doi: 10.3390/ijerph17093144.
15. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Public Health. 2008 Oct 23; 8: 368. doi: 10.1186/1471-2458-8-368.
16. Endarti D, Satibi S, Kristina SA, Farida MA, Rahmawanti Y, Andriani T. Knowledge, Perception, and Acceptance of HPV Vaccination and Screening for Cervical Cancer among Women in Yogyakarta Province, Indonesia. Asian Pac J Cancer Prev. 2018 Apr 27; 19(4): 1105-11. doi: 10.22034/APJCP.2018.19.4.1105.
17. Yerramilli P, Dugee O, Enkhtuya P, Knaul FM, Demaio AR. Exploring Knowledge, Attitudes, and Practices Related to Breast and Cervical Cancers in Mongolia: A National PopulationBased Survey. Oncologist. 2015 Nov; 20(11): 1266-73. doi: 10.1634/theoncologist.2015-0119. Epub 2015 Sep 28.
18 Islam JY, Khatun F, Alam A, et al. Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study. BMC Womens Health. 2018 Jan 11; 18(1):
15. doi: 10.1186/s12905-018-0510-7.
19. Tran BX, Than PTQ, Doan TTN, et al. Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam. Patient
Prefer Adherence. 2018 May 30; 12: 945-54. doi: 10.2147/PPA.S165357.
20. Chidyaonga-Maseko F, Chirwa ML, Muula AS. Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J. 2015 Jul 30; 21: 231. doi: 10.11604/ pamj.2015.21.231.6350.
21. Vietnam Ministry of Health. Guidelines on the Implementation of Infection Control in Health Care Institutions. Vietnam Ministry of Health; 2009.
22. Fesenfeld M, Hutubessy R, Jit M. Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. Vaccine. 2013 Aug 20; 31(37): 3786-804. doi: 10.1016/j.vaccine.2013.06.060. Epub 2013 Jul 3.
23. Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS One. 2014 Mar 11; 9(3): e90912. doi: 10.1371/ journal.pone.0090912.
24. WHO and UNICEF warn of a decline in vaccinations during COVID-19. 15 July 2020. Available on: https://www.who.int/news/ item/15-07-2020-who-and-unicef-warn-of-adecline-in-vaccinations-during-covid-19 [Last accessed: 2023 Apr 3].
25. Ojeleye OA, Adejumo PO. Knowledge and acceptance of HPV vaccination among Lagos students. Afr J Midwifery Womens Health. 2019 Apr; 13(2): 1-8. https://doi.org/10.12968/ AJMW.2018.0003.
26. PATH (Global Health Organization). Shaping a Strategy to Introduce HPV Vaccines in Vietnam: Formative Research Results from the HPV Vaccines: Evidence for Impact Project.
2009. Available on: https://screening.iarc.fr/doc/
PATH_FRTS_execsumm_Vietnam.pdf [Last accessed: 2023 Apr 3].
27. Wong LP. Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician’s perspective. J Community Health. 2011 Feb; 36(1): 14-22. doi: 10.1007/s10900010-9275-0.
28. Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med. 2014 Jan; 58: 22-
32. doi: 10.1016/j.ypmed.2013.10.009. Epub 2013 Oct 28.
29. Qin S, Fu JX, Chen MZ, Meng YT, Xu C, Luo Y. Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study. Vaccine. 2020 Jun 19; 38(30): 4732-9. doi: 10.1016/j.vaccine.2020.05.017. Epub 2020 May 26.
30. Khatiwada M, Kartasasmita C, Mediani HS, Delprat C, Van Hal G, Dochez C. Knowledge, Attitude and Acceptability of the Human Papilloma Virus Vaccine and Vaccination Among University Students in Indonesia. Front Public Health. 2021 Jun 14; 9: 616456. doi: 10.3389/ fpubh.2021.616456.
31. World Health Organization (WHO). Regional Office for Western Pacific. Report of the 2019 global school-based student health survey in Viet Nam. 24 April 2022. Available on: https://www. who.int/publications/i/item/9789290619376 [Last accessed: 2023 Apr 3].
32. Bhuiyan A, Sultana F, Islam JY, Chowdhury MAK, Nahar Q. Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study. Biores Open Access. 2018 May 1; 7(1): 63-72.
doi: 10.1089/biores.2018.0007.
33. Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014 Jul 9; 14: 700. doi:
10.1186/1471-2458-14-700.
34. Duong ML, Pham VL, Pham TT, et al. DNAHPV transition rate and related factors in HPVinfected women in Can Tho city, Vietnam. Trop Med Int Health. 2019 Nov; 24(11): 1330-4. doi:
10.1111/tmi.13309. Epub 2019 Oct 3.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.